Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer

Won Tae Kim, Seok Joong Yun, Cheol Park, Isaac Yi Kim, Sung Kwon Moon, Tae Gyun Kwon, Yung Hyun Choi, Wun Jae Kim

    Research output: Contribution to journalArticlepeer-review

    11 Scopus citations


    Purpose: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with invasive bladder cancer, and expression of the C16orf74 gene locus has been shown to correlate positively with PRSS3. The aim of the current study was to evaluate the relationship between C16orf74 expression level and progression in non-muscle invasive bladder cancer (NMIBC). Materials and Methods: C16orf74 mRNA levels were examined by real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of 193 tumor specimens from patients with primary NMIBC. Expression data were analyzed in terms of clinical and experimental parameters. Kaplan-Meier curves and multivariate Cox regression models, respectively, were used to determine progression-free survival and to identify independent predictive parameters of progression. Results: Analysis using Kaplan-Meier curves revealed prolonged progression-free survival of high-C16orf74-expressors as compared to low-expressors (p<0.001). Multivariate Cox regression analysis revealed that low C16orf74 mRNA expression levels are a significant risk factor for disease progression in patients with primary NMIBC (HR: 10.042, CI:2.699-37.360, p = 0.001). Conclusions: Decreased expression of C16orf74 correlates significantly with progression in primary NMIBC. C16orf74 expression level represents a potentially useful marker for predicting progression in primary NMIBC patients.

    Original languageEnglish (US)
    Article numbere15260
    JournalPloS one
    Issue number12
    StatePublished - 2010

    All Science Journal Classification (ASJC) codes

    • Biochemistry, Genetics and Molecular Biology(all)
    • Agricultural and Biological Sciences(all)
    • General


    Dive into the research topics of 'Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer'. Together they form a unique fingerprint.

    Cite this